ABSTRACT Mouse L cells transfected with a genomic clone containing the H-2Ld gene (8-5 cells) were shown to function as targets for H-2Ld-specific cytotoxic T lymphocytes (CTL). The CTL-mediated lysis of 8-5 cells was shown to be H-2Ld specific by the use of(i) CTL with restricted reactivity, (ii) unlabeled target inhibition, and (iii) monoclonal antibody inhibition. We also demonstrated that 8-5 cells could function as targets for antibody-pluscomplement-mediated cell lysis. Specificity was confirmed by using H-2Ld-specific monoclonal antibodies. These experiments demonstrate that the gene products of a major histocompatibility complex genomic clone can be functionally expressed in a foreign cell and can mediate immunologically specific cellular interactions.
Early interest in the major histocompatibility complex (MHC) derived from its role in the rejection ofallografts, cell-mediated cytotoxic responses, and mixed lymphocyte reactions. It was subsequently learned that such "unrestricted" allogeneic reactions are an exception among the array ofimmune responses; immune cellular collaboration and T-cell specificity are generally restricted by recognition of self MHC determinants (1, 2) . Thus it has become of interest to determine not only the effects of manipulating alloimmune responses but also the effects of manipulating MHC determinants themselves.
Until now, immunogenetic analysis of the mouse MHC, H-2, has been dependent upon the occurrence of intra-H-2 recombinants or MHC mutants as a source of MHC variant cells. Recently, however, the availability of cloned cDNA probes for MHC antigens has allowed the isolation of several appropriate genomic DNA clones from a BALB/c sperm DNA library (3).
One genomic clone, 27.5, was shown to contain the H-2Ld gene by DNA-mediated gene transfer into mouse L cells (4) . The ability to place foreign H-2 molecules on the surface of cells by means of transformation with cloned H-2 genes provides a method of manipulating given H-2 genes in vitro and studying the immune properties of their cell surface products after gene transfer.
A rigorous correlation between 27.5 gene transfer and the expression ofH-2Ld molecules has been established by the reactivity of H-2Ld-specific monoclonal antibodies with the 27.5-transfected L-cell clone, 8-5 (4) . In order to determine whether the H-2Ld molecule on 8-5 cells was expressed in a biologically relevant way, we evaluated whether the H-2Ld product could also be recognized by cytotoxic T lymphocytes (CTL (5) . With H-2d mice, monoclonal 28-14-8S detects both H-2Ld and H-2Rd molecules, whereas monoclonal 30-5-7S is reactive with H-2Ld exclusively (6) . Monoclonals 4-9.4, 5-7.1, 6-27.10, 7-16.20, 7-16 .32, and 7-30.2 were produced in our laboratory according to published techniques (7) and will be described in detail elsewhere. Monoclonal 4-9.4 originated from a B10.P anti-B10.Q immunization and has a haplotype distribution pattern corresponding to specificity H-2.65 (reacts with H-2dq; does not react with H_2b kf.P r S jdm2). That 4-9.4 reacts with BALB/c but not CH-22dm2 cells indicates that it detects H-2Ld or H-2Rd molecules or both; the results described in this manuscript indicate that it recognizes at least H-2Ld products. Monoclonals 5-7.1, 6-27.10, 7-16.32, and 7-30.2 were selected as controls on the basis of their reactivity with H-2Kd-or H-2Kk-encoded determinants and their lack of activity with H-2D region-encoded products.
Abbreviations: Con A, concanavalin A; CTL, cytotoxic T lymphocyte; HAT, hypoxanthine/aminopterin/thymidine; MHC, major histocompatibility complex; TK, thymidine kinase.
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The C-H-2dm2 anti-BALB/c antiserum used here was obtained from Ted Hansen (Merck Sharp & Dohme, Rahway, NJ (Fig. 1) (Fig. 4) cific antiserum, C-H-2dm2 anti-BALB/c, and an H-2Ld-specific monoclonal, 28-14-8S, significantly inhibited lysis of8-5 targets but no inhibition by these reagents was seen with B10.OH targets (Fig. 5) . Interestingly, another H-2Ldspecific monoclonal, 4-9.4, failed to show significant inhibition of 8-5 lysis. Because 4-9.4 did show reactivity toward 8-5 cells in complement-dependent cytotoxicity assays (Table 2) , its inability to block CTL recognition may reflect a specificity on the H-2Ld molecule not seen readily (or at least in high frequency) by the CTL. (6, 13) . Because there are no recombinants among these genes, it was not possible to distinguish among D-, L-, R-, and M-specific killing by using D-restricted killers or unlabeled target inhibition although these experiments localized the specificity to the D region. However, further specificity was achieved by using the loss mutant C-H2dm2, which fails to express both H-2L and H-2Rd molecules (6) . C-H-2dm2 anti-BALB/c effectors specifically lysed 8-5 cells, thus narrowing the specificity down to the H-2Ld or Rd molecule. Finally, monoclonal antibody inhibition experiments showed that two H-2Ld specific monoclonals could almost completely block CTL recognition and lysis of 8-5 cells, thereby demonstrating that the relevant CTL target antigen on 8-5 cells is, in fact, the H-2Ld molecule. In no case was H-2d-specific killing detected on Ltk+ cells, indicating that the transfection procedure itself did not result in expression of H-2d specificities.
We also demonstrated that H-2Ld molecules expressed on 8-5 cells can serve as targets for antibody-dependent complement-mediated lysis. Three H-2Ld-specific monoclonals were selectively cytotoxic on 8-5 cells but were unreactive with Ltk' cells. One monoclonal reagent, 4-9.4, was specifically cytotoxic for 8-5 cells but failed to block significantly their lysis by CTLs, even at a concentration well above its cytotoxic titer. This may reflect a serologic specificity on the Ld molecule not efficiently recognized by CTLs. Alternatively, the concentration of 4-9.4 antibody used may not have been sufficient to bind with enough of the available H-2Ld molecules to block their recognition by CTLs completely. Monoclonal antibodies with similar CTL blocking properties have been reported by Weyand et al. (14) for other MHC antigens.
The successful transfer and functional expression of a cloned gene coding for cell-surface recognition molecules provides a powerful approach for study of the structure-function relationships of these molecules. Thus, it is now technically possible to produce, by in vitro recombination and site-directed mutagenesis, molecules that have precisely defined alterations in the sequence. With these novel H-2 molecules, it will be possible to evaluate the effects of these alterations on the functional expression of the gene products. By using these techniques, H-2 molecules with known sequence deletions or substitutions of entire domains or of single amino acids can be produced. It then will be possible to map the areas ofthe H-2 molecules that are responsible for CTL recognition. It will also be possible to determine if H-2 molecules, like immunoglobulins, have domains specialized for different biological functions.
Finally, the technique should prove useful for the identification of genes coding for cell-surface products with similar structures and for the determination of their function. By using monoclonal antibodies and MHC-specific T-cell clones to analyze transformants expressing different cloned genes, it will be possible to assess the true diversity of functional MHC molecules and to probe the fine structure of the H-2 gene complex.
